How biotech executives are confronting the funding and regulatory shifts - Pharmaceutical Technology

Amidst regulatory turmoil and a funding resurgence, companies provide insights on how they are navigating the changing industry. Amidst regulatory turmoil and a funding resurgence, companies provide insights on how they are navigating the changing industry. Businessman stand in front of maze entrance. Business problem solving, making decision, finding solution and challenge concept. Following an influx of capital in the early COVID-19 pandemic, the biotech sector entered a sustained investment slump. Now the industry finally appears to be signalling renewed momentum. There has been a sharp rebound in the number of IPOs since the start of 2026. In addition, M&A…

Source: Pharmaceutical Technology